Medication | Action | Used | Not Used |
Codeine | It is a central nervous system (CNS) depressant. It changes the way the body or brain responds to pain. | Painkiller, cough suppressant and treats mild to severe pain. | Postoperative pain in children, paralytic Ileus, hypercapnia, acute or severe bronchial asthma and respiratory depression. |
Hydrocodone | Specific CNS opioid receptors for endogenous compounds with opioid-like activity and play a role in the analgesic effects of this drug | Use in the management of severe pain that require the use of opioids. | Hypersensitivity to hydrocodone, acute or severe bronchial asthma, respiratory depression and suspected gastrointestinal obstruction |
Hydromorphone | It is an agonist at the mu opioid peptide receptor/it has a weaker affinity at the kappa and delta opioid peptide receptors. | Same as above | Same as above |
Oxycodone | A semisynthetic opioid with agonistic properties on the different opioid receptors. It has the strongest affinity for mu-type receptors. | Used for all types of pain especially in cases where other medications showed failure | Same as above |
Methadone | It is a synthetic opioid, it induces other opioid receptors. Methadone activates the μ-receptors in the same pathway as the above mentioned opioids. | Manages pain that is non-responsive to non-narcotic drugs. Treatment of neonatal abstinence syndrome | CNS-related pathologies such as trauma, delirium, etc. Not to be used in conjunction with medications or substances with similar depressant effects |
Morphine | It binds to the mu-opioid receptor in the CNS and the PNS to reduce nociceptive transmission. | Moderate to severe pain that may be acute or chronic especially in the management of palliative care, in active cancer treatment, and vaso-occlusive pain during sickle cell crisis. | It should be avoided in severe respiratory depression, asthma exacerbation cases and in cases of previous hypersensitivity reaction and immediately discontinued in the presence of an active reaction. |
Acetaminophen | It acts as an inhibitor for the cyclooxygenase (COX) pathways. | It is an antipyretic and a non-opioid analgesic agent. | Hypersensitivity to acetaminophen and severe hepatic impairment. |
Non-steroidal anti-inflammatory drugs (NSAIDs) | Inhibition cyclooxygenase thus leading to lack of eicosanoids such as prostaglandins which has an anti-nociception activity. | Used to treat pain, fever, and other inflammatory processes. | Hypersensitivity to NSAIDs, patients who have undergone coronary artery bypass graft and third trimester pregnancy |
Antidepressants | They increase neurotransmitters serotonin or norepinephrine or both in the synapse. | Depression, pain, insomnia and migraine | Hypersensitivity to antidepressants, cardiovascular disease |
Tricyclic antidepressants | Work by inhibiting the reuptake of serotonin and norepinephrine. | Same as above | Patients with orthostatic hypotension, bundle-branch disease |
Musculoskeletal agents | There are two types; antispasmodics and antispasticity. The latter works directly on the skeletal muscle and on the spinal cord. Antispasmodics alters conduction in the CNS hence decrease muscle spasms. | They are used as muscle relaxants and musculoskeletal spasmodic pain. | Severe hepatic and renal dysfunction and patients who have hypersensitivity to these agents. |
Topical analgesics | Its mode of actions is the same as described above, but are applied transdermally. | Management of moderate to severe acute and chronic pain | Patients who have sympathetic systems blocks |